Navigation Links
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
Date:8/19/2008

EAST SETAUKET, N.Y., Aug. 19 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) and Lixte filed a joint patent application identifying a biomarker, present in many common cancers, that is a target of drugs being evaluated by Lixte and NINDS for the treatment of brain tumors.

Dr. John S. Kovach, President and CEO of Lixte, said, "Studies with the research team at the Molecular Pathogenesis Unit, Surgical Neurology Branch, NINDS, identified a biomarker that appears to be preferentially targeted by novel anti-cancer drugs currently being evaluated by NINDS and Lixte as new treatments for human brain tumors. Molecular studies revealed that these drugs alter the state of this biomarker in a way that leads to the death of cancer cells. Since the biomarker appears to be important to the survival of several human cancers in addition to brain cancers, studies will be done to determine the effectiveness of targeting the biomarker in other tumor types and as a guide to drug discovery of new anti-cancer compounds."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers.

About the National Institute of Neurological Disorders and Stroke (NINDS), (NIH):

NINDS (http://www.ninds.nih.gov) is a component of the National Institutes of Health (NIH), and is the nation's primary supporter of biomedical research on the brain and nervous system.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
2. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
3. BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
4. Yongye Biotechnology International Announces Second Quarter Results
5. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
6. Yongye Biotechnology International Retains CCG Investor Relations
7. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
8. New Book on the Business of Biotechnology
9. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
10. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
11. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)...  Pomerantz LLP announces that a class action lawsuit ... the "Company")(NYSE: PBYI ) and certain of its ... Court, Central District of California , ... class consisting of all persons or entities who purchased ... 2015 inclusive (the "Class Period").  This class action seeks ...
(Date:7/2/2015)... Scotland , July 2, 2015 ... Bio-tech procurement company Amici Procurement has chosen ... to help it move to Office 365. ... provides small to medium-sized companies in the bio-tech ... all aspects of the purchasing cycle to help them ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... 2015 Isagenix International, a leading global health ... three Silver, and three Bronze Stevie® Awards at the ... Chicago this month.The American Business ... program in the U.S. "Winning is ... developing leaders, cultivating talent, creating a unified team, and ...
Breaking Biology Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4Biotech Procurement Company Moves to Office 365 with iomart 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
... ... for the synthesis lab and synthetic organic chemist - heating and cooling without an additional ... first automated chemistry development tool that requires no training, EasyMax™, and the chance to WIN ... ...
... Reinstates Booster Dose of Hib Vaccine - , , ... the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY ), ... supply of its Hib-containing vaccines to enable the return to a ... increased supply, on July 1, the U.S. Centers for Disease Control ...
... June 25 DuPont (NYSE: DD ) ... long-term business agreements related to key plant biotechnology traits ... around the world. , , These agreements ... herbicide and seed sales as well as royalties. ...
Cached Biology Technology:Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax™: the First Automated Chemistry Development Tool That Requires No Training 2Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply 2Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply 3Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply 4Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply 5Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply 6DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 2DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 3DuPont and Bayer CropScience Expand Collaboration With Broad License Agreements 4
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/25/2015)... 2015 According to a ... & Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive ... & Others) & Geography - Global Forecast to ... market is expected to reach $14,500.07 Million by ... Browse 76 market Tables and 109 Figures ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... Systems market, over the next six years. It contains ... affect the industry, along with their impact from the ... It also discusses the industry, market, and technology ... expected that the need of concerned authorities to efficiently ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... lose weight won,t need to track their daily food ... at the University of Pittsburgh. eButton -- a device ... a miniature camera, accelerometer, GPS, and other sensors -- ... need for daily self-reporting. The eButton prototype was the ...
... new method for visualizing mechanical forces on the surface of ... first detailed view of those forces, as they occur in ... been measured before: The force that one molecule applies to ... and as this cell moves and goes about its normal ...
... a bacterium that holds potential for removing toxic and ... a study by researchers with the U.S. Department of ... researchers have provided the first ever map of the ... surrounding environment. "Knowing how bacteria respond to environmental ...
Cached Biology News:Pitt researchers develop eButton, an easier way to monitor food intake, exercise, and lifestyle 2Chemists reveal the force within you 2Chemists reveal the force within you 3Berkeley Lab researchers create first of its kind gene map of sulfate-reducing bacterium 2Berkeley Lab researchers create first of its kind gene map of sulfate-reducing bacterium 3
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... modifications of Grace's medium were developed in ... 1970's. Many of these modifications were developed ... of cells derived from the cabbage looper,Tricoplusia ... as TNM-FH. The medium when properly supplemented ...
... The LIC Duet™ GST•Tag™ Ek Adaptor ... operator, ribosome binding site (rbs), ATG translation ... sequence. The GST•Tag sequence has been reported ... cases the solubility of its fusion partners. ...
...
Biology Products: